BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21793965)

  • 21. Effects of avotermin (transforming growth factor β3) in a clinically relevant pig model of long, full-thickness incisional wounds.
    Laverty HG; Occleston NL; Johnson M; Little J; Jones R; Fairlamb D; Ferguson MW; O'Kane S
    J Cutan Med Surg; 2010; 14(5):223-32. PubMed ID: 20868619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in plasma Transforming growth factor beta-1 and post-burn scarring in children.
    Rorison P; Thomlinson A; Hassan Z; Roberts SA; Ferguson MW; Shah M
    Burns; 2010 Feb; 36(1):89-96. PubMed ID: 19524370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation.
    Profyris C; Tziotzios C; Do Vale I
    J Am Acad Dermatol; 2012 Jan; 66(1):1-10; quiz 11-2. PubMed ID: 22177631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen peroxide disrupts scarless fetal wound repair.
    Wilgus TA; Bergdall VK; Dipietro LA; Oberyszyn TM
    Wound Repair Regen; 2005; 13(5):513-9. PubMed ID: 16176460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model.
    Mak K; Manji A; Gallant-Behm C; Wiebe C; Hart DA; Larjava H; Häkkinen L
    J Dermatol Sci; 2009 Dec; 56(3):168-80. PubMed ID: 19854029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
    Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New potential antiscarring approaches.
    Liu W; Wu X; Gao Z
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s22-31. PubMed ID: 21793963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
    Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
    Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scarless skin wound repair in the fetus.
    Lorenz HP; Adzick NS
    West J Med; 1993 Sep; 159(3):350-5. PubMed ID: 8236977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Control of wound healing after glaucoma surgery. Effect and inhibition of the growth factor TGF-beta].
    Wimmer I; Grehn F
    Ophthalmologe; 2002 Sep; 99(9):678-82. PubMed ID: 12219255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
    Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
    Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved scar quality following primary and secondary healing of cutaneous wounds.
    Atiyeh BS; Amm CA; El Musa KA
    Aesthetic Plast Surg; 2003; 27(5):411-7. PubMed ID: 14648065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues.
    Ghahary A; Shen YJ; Scott PG; Gong Y; Tredget EE
    J Lab Clin Med; 1993 Oct; 122(4):465-73. PubMed ID: 8228562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study on the expressions and the correlation of TGF-beta and alpha-SMA in scars].
    Tian Y; Tang S; Luo S
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):75-7. PubMed ID: 11593622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing: quantitative volumetric scar improvement.
    Weiss ET; Chapas A; Brightman L; Hunzeker C; Hale EK; Karen JK; Bernstein L; Geronemus RG
    Arch Dermatol; 2010 Feb; 146(2):133-40. PubMed ID: 20157023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation.
    Xia YP; Zhao Y; Marcus J; Jimenez PA; Ruben SM; Moore PA; Khan F; Mustoe TA
    J Pathol; 1999 Aug; 188(4):431-8. PubMed ID: 10440755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds.
    Vooijs DP; Walboomers XF; Parker JA; Von den Hoff JW; Jansen JA
    J Biomed Mater Res A; 2004 Sep; 70(3):402-11. PubMed ID: 15293313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children.
    de Oliveira GV; Sanford AP; Murphy KD; de Oliveira HM; Wilkins JP; Wu X; Hawkins HK; Kitten G; Chinkes DL; Barrow RE; Herndon DN
    Wound Repair Regen; 2004; 12(4):404-11. PubMed ID: 15260805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wound healing: from embryos to adults and back again.
    Tredget EE; Ding J
    Lancet; 2009 Apr; 373(9671):1226-8. PubMed ID: 19362658
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring.
    Kryger ZB; Sisco M; Roy NK; Lu L; Rosenberg D; Mustoe TA
    J Am Coll Surg; 2007 Jul; 205(1):78-88. PubMed ID: 17617336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.